China SXT Pharmaceuticals Inc Cl A

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 11:21

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeNASDAQ

Market Capitalization0.3811 mln

Earnings Date09/19/2025

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

-1.54

Likely manipulated

Relative Strength

1 / 100

Severely lagging

Debt / Equity

0.04

Debt-free

Pre-Tax Margin

-545%

Severely loss-making

ROE

-28.47

Deeply negative

Business Description

Founded in 2005 and based in Taizhou, China, China SXT Pharmaceuticals develops, produces, and sells a wide range of traditional Chinese medicine products. The company supplies raw medicinal materials alongside premium and standard processed medicine products to hospitals, pharmacies, pharmaceutical companies, and distributors across China. Its products are sold under several well-known brands, including Suxuantang, Hui Chun Tang, and Tong Ren Tang.

Key Fundamentals

EPS-73,040

ROE-28.47

RPS1.67

ROIC-201

ROA-22.49

Interest Cover-170

EBITDA, mln-6.00

EV / EBITDA3.83

EV / EBIT3.74

Revenue, mln1.14

Quote Details

Last 3.45

Change -0.09 (-2.54%)

Open 3.47

Volume 94,770

Turnover 326,956

Average Volume 579,663

Financial Ratios

Pre-Tax Profit Margin-545

Leverage Ratio1.17

Current Ratio7.94

Price / Book0.00

Debt / Equity0.04

Price / Sales0.03

Financial Strength

Altman Z-Score-0.45

Piotroski F-Score 3 / 9

Beneish M-Score-1.54

Short Ratio0.08

Short % of Float4.96

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-47.17%	0 / 100
1 Month	-98.63%	0 / 100
2 Months	-99.98%	0 / 100
6 Months	-99.98%	0 / 100
1 Year	-100%	0 / 100